Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Israel and UAE Medical Collaboration: Sheba Physicians Will Travel to Dubai, Treat Security Personnel and Train Medical Personnel

Sheba Physicians Will Travel to the UAE
Face-to-face diagnostic consultations will be held with an initial 350 diabetes patients in the UAE military, police, and firefighting services, all part of the Israel and UAE medical collaboration.

Following an agreement reached between the Dubai-based Al Tadawi Healthcare Group and Sheba Medical Center as part of the Israel and UAE medical collaboration, doctors from Sheba will fly to Dubai for face-to-face diagnostic consultations with an initial 350 diabetes patients in the UAE military, police, and firefighting services, then follow-up with remote monitoring.

Separately, Sheba will be sending physicians to train personnel at Medcare Women & Children Hospital in Dubai, in various fields including fetal medicine.

According to the Director of the International Division & Resource Development at Sheba Medical Center, Yoel Har-Even, Sheba “is moving quickly to establish a permanent presence in the UAE and to expand its offerings … The next steps are very, very close.”


Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More
Hemophilia research
News Sep 05.

New Sheba Study Indicates: Novel Treatment Sharply Reduces Bleed Rates Among Hemophilia Patients

Results indicate that a monthly treatment with Fitusiran significantly reduces bleed rates among both hemophilia A and B patients.
Read More